AR017298A1 - USO DE UN COMPUESTO DERIVADO DE DEPSIPEPTIDO DOLASTINA-15 (Dov-Val-NMeVal-Pro-Pro-Hiva-Dpy) PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA ELTRATAMIENTO DE ARTRITIS REUMATOIDEA EN UN MAMIFERO - Google Patents
USO DE UN COMPUESTO DERIVADO DE DEPSIPEPTIDO DOLASTINA-15 (Dov-Val-NMeVal-Pro-Pro-Hiva-Dpy) PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA ELTRATAMIENTO DE ARTRITIS REUMATOIDEA EN UN MAMIFEROInfo
- Publication number
- AR017298A1 AR017298A1 ARP980104972A ARP980104972A AR017298A1 AR 017298 A1 AR017298 A1 AR 017298A1 AR P980104972 A ARP980104972 A AR P980104972A AR P980104972 A ARP980104972 A AR P980104972A AR 017298 A1 AR017298 A1 AR 017298A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbonyl
- alkyl
- tert
- isoleucyl
- residue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Uso de un compuesto derivado del depsipéptido Dolastatina-15 (Dov-Val-NMeval-Pro-Pro-Hiva-Dpy) de la formula (I) R1R2N-CHX-CO-A-B-D-(E)s -(F)t -(G)u -K endonde: R1 es alquilo C1-3; cicloalquilo, tal como ciclopropilo; alquilsulfonilo C1-3; fluoroalquilo, tal como fluoroetilo, difluoretilo, fluoroisopropilo,aminosulfonilo que puede ser sustituido por alquilo, tal como metilo; R2 es hidrogeno; alquilo C1-3; fluoroalquilo, tal como fluoroetilo, difluoroetilo,fluorisopropilo; cicloalquilo, tal comociclopropilo; R1-N-R2 juntos pueden ser un residuo pirrolidino o piperidino; A es un valilo, isoleucilo,leucilo, alo-isoleucilo, 2,2-dimetilglicilo, 2-ciclopropilglicilo, 2-ciclopentilglicilo, 3-ter-butilalanilo, 2-ter-butilglicilo, 3-cicloexilalanilo2-etilglicilo, 2-ciclohexilglicilo, residuo norleucilo o norvalilo; B es un N-alquil-valilo, -norvalilo, -leucilo, -isoleucilo, -2-ter-butilglicilo,-3-ter-butilalanilo, -2-etilglicilo, -2-ciclopropilglicilo, norleucilo o residuo -2-ciclohexilglicilodonde N- alquilo es preferentemente N-metilo o N -etilo;D y E es propilo, homoprolilo, hidroxiprolilo, 3,4-deshidroprolilo, 4-fluoroprolilo, 3-metilprolilo, 4-metilprolilo, 5-metilprolilo, azetidin-2-carbonilo, 3,3-dimetilprolilo, 4,4-difluoroprolilo, oxalidin-4-carbonilo o residuo tiazolidin-4-carbonilo;F y G se seleccionan independientemente del grupo que consiste de prolilo, homoprolilo, hidroxiprolilo, tiazolidinil-4-carbonilo1-aminopentil-1-carbonilo, valilo, 2-ter-butilglicilo, isoleucilo, leucilo, 3-ciclohexilalanilo, fenilalanilo, N-metilfenilalanilo, tetrahidroisoquinolil-2-histidilo, 1-aminoindil-1-carbonilo, 3-piridilalanilo, 2-ciclohexilglicilo, norleucilo, norvalilo, neopentilglicilo, tritofanilo, glicilo, 2,2-dimetilglicilalanilo, beta-alanilo y residuos 3-naftilalanilo; X es hidrogeno, alquilo (tal como C1-5), cicloalquilo (tal como C3-7), -CH2-ciclohexilo o arilalquilo (tal
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/944,479 US6015790A (en) | 1997-10-06 | 1997-10-06 | Methods and compositions for treating rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017298A1 true AR017298A1 (es) | 2001-09-05 |
Family
ID=25481479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104972A AR017298A1 (es) | 1997-10-06 | 1998-10-06 | USO DE UN COMPUESTO DERIVADO DE DEPSIPEPTIDO DOLASTINA-15 (Dov-Val-NMeVal-Pro-Pro-Hiva-Dpy) PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA ELTRATAMIENTO DE ARTRITIS REUMATOIDEA EN UN MAMIFERO |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6015790A (es) |
| EP (1) | EP1021200B1 (es) |
| JP (1) | JP2001518515A (es) |
| KR (1) | KR20010081900A (es) |
| CN (1) | CN1278734A (es) |
| AR (1) | AR017298A1 (es) |
| AT (1) | ATE212855T1 (es) |
| AU (2) | AU748465B2 (es) |
| BG (1) | BG104292A (es) |
| BR (1) | BR9812875A (es) |
| CA (1) | CA2305688A1 (es) |
| DE (1) | DE69803792D1 (es) |
| DK (1) | DK1021200T3 (es) |
| ES (1) | ES2173626T3 (es) |
| HR (1) | HRP20000265A2 (es) |
| HU (1) | HUP0101715A3 (es) |
| IL (1) | IL135167A0 (es) |
| NO (1) | NO20001758L (es) |
| PL (1) | PL339731A1 (es) |
| PT (1) | PT1021200E (es) |
| SK (1) | SK4272000A3 (es) |
| TR (1) | TR200000903T2 (es) |
| WO (2) | WO1999017792A1 (es) |
| ZA (1) | ZA989036B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010009901A1 (en) | 1996-12-11 | 2001-07-26 | Basf Aktiengesellschaft Germany | Antineoplastic peptides |
| KR100261114B1 (ko) * | 1998-01-24 | 2000-07-01 | 박종헌 | 히스톤을 함유하는 류마티스 관절염 치료제 조성물 |
| AU6464400A (en) * | 1999-09-14 | 2001-04-17 | Pfizer Products Inc. | Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
| WO2001041789A1 (fr) * | 1999-12-07 | 2001-06-14 | Santen Pharmaceutical Co., Ltd. | Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif |
| ATE339404T1 (de) | 1999-12-24 | 2006-10-15 | Hoffmann La Roche | Nitrilderivate als cathepsin k hemmer |
| AU2007343454A1 (en) * | 2007-01-09 | 2008-07-17 | Bayer Schering Pharma Aktiengesellschaft | Radiolabelling via fluorination of aziridines |
| EP2443136A4 (en) | 2009-06-18 | 2013-01-09 | Strongbone Ab | NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR MITIGATION OF AFFECTION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR INHIBITING DIFFERENTIATION AND STIMULATION OF OSTEOCLASTS |
| RU2655604C2 (ru) * | 2013-01-11 | 2018-05-29 | Фуджифилм Корпорэйшн | Азотсодержащее гетероциклическое соединение или его соль |
| KR102372512B1 (ko) * | 2017-11-20 | 2022-03-10 | 가톨릭대학교 산학협력단 | 폴리감마글루탐산 및 메토트렉세이트를 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물 |
| CN115281149A (zh) * | 2021-05-12 | 2022-11-04 | 四川大学华西医院 | 一种临床前类风湿关节炎(Pre-RA)小鼠模型 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816444A (en) * | 1987-07-10 | 1989-03-28 | Arizona Board Of Regents, Arizona State University | Cell growth inhibitory substance |
| US4879278A (en) * | 1989-05-16 | 1989-11-07 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| DE69230824T2 (de) * | 1991-08-09 | 2000-07-27 | Teikoku Hormone Mfg Co Ltd | Neue tetrapeptidderivate |
| US5831002A (en) * | 1992-05-20 | 1998-11-03 | Basf Aktiengesellschaft | Antitumor peptides |
| DE69329425T2 (de) * | 1992-12-16 | 2001-01-18 | Basf Ag | Dolastatin analog |
| US5504191A (en) * | 1994-08-01 | 1996-04-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide methyl esters |
| US5530097A (en) * | 1994-08-01 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory peptide amides |
| US5583153A (en) * | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
-
1997
- 1997-10-06 US US08/944,479 patent/US6015790A/en not_active Expired - Fee Related
-
1998
- 1998-09-24 TR TR2000/00903T patent/TR200000903T2/xx unknown
- 1998-09-24 PT PT98948455T patent/PT1021200E/pt unknown
- 1998-09-24 CN CN98811034A patent/CN1278734A/zh active Pending
- 1998-09-24 DK DK98948455T patent/DK1021200T3/da active
- 1998-09-24 EP EP98948455A patent/EP1021200B1/en not_active Expired - Lifetime
- 1998-09-24 AU AU95024/98A patent/AU748465B2/en not_active Ceased
- 1998-09-24 AT AT98948455T patent/ATE212855T1/de not_active IP Right Cessation
- 1998-09-24 WO PCT/US1998/019841 patent/WO1999017792A1/en not_active Application Discontinuation
- 1998-09-24 CA CA002305688A patent/CA2305688A1/en not_active Abandoned
- 1998-09-24 IL IL13516798A patent/IL135167A0/xx unknown
- 1998-09-24 SK SK427-2000A patent/SK4272000A3/sk unknown
- 1998-09-24 PL PL98339731A patent/PL339731A1/xx not_active Application Discontinuation
- 1998-09-24 ES ES98948455T patent/ES2173626T3/es not_active Expired - Lifetime
- 1998-09-24 JP JP2000514663A patent/JP2001518515A/ja not_active Withdrawn
- 1998-09-24 DE DE69803792T patent/DE69803792D1/de not_active Expired - Fee Related
- 1998-09-24 BR BR9812875-2A patent/BR9812875A/pt not_active IP Right Cessation
- 1998-09-24 KR KR1020007003706A patent/KR20010081900A/ko not_active Application Discontinuation
- 1998-09-24 HU HU0101715A patent/HUP0101715A3/hu unknown
- 1998-09-30 AU AU95926/98A patent/AU9592698A/en not_active Withdrawn
- 1998-09-30 WO PCT/US1998/020465 patent/WO1999017709A2/en active Application Filing
- 1998-10-05 ZA ZA9809036A patent/ZA989036B/xx unknown
- 1998-10-06 AR ARP980104972A patent/AR017298A1/es not_active Application Discontinuation
-
2000
- 2000-04-03 BG BG104292A patent/BG104292A/xx unknown
- 2000-04-05 NO NO20001758A patent/NO20001758L/no not_active Application Discontinuation
- 2000-05-04 HR HR20000265A patent/HRP20000265A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK4272000A3 (en) | 2001-02-12 |
| IL135167A0 (en) | 2001-05-20 |
| DK1021200T3 (da) | 2002-05-27 |
| PT1021200E (pt) | 2002-07-31 |
| WO1999017709A2 (en) | 1999-04-15 |
| CA2305688A1 (en) | 1999-04-15 |
| WO1999017792A1 (en) | 1999-04-15 |
| CN1278734A (zh) | 2001-01-03 |
| ES2173626T3 (es) | 2002-10-16 |
| JP2001518515A (ja) | 2001-10-16 |
| BG104292A (en) | 2000-12-29 |
| KR20010081900A (ko) | 2001-08-29 |
| HUP0101715A2 (hu) | 2001-11-28 |
| ATE212855T1 (de) | 2002-02-15 |
| EP1021200B1 (en) | 2002-02-06 |
| ZA989036B (en) | 2000-04-05 |
| HUP0101715A3 (en) | 2001-12-28 |
| AU9502498A (en) | 1999-04-27 |
| AU748465B2 (en) | 2002-06-06 |
| HRP20000265A2 (en) | 2000-12-31 |
| NO20001758L (no) | 2000-06-05 |
| TR200000903T2 (tr) | 2001-07-23 |
| AU9592698A (en) | 1999-04-27 |
| NO20001758D0 (no) | 2000-04-05 |
| PL339731A1 (en) | 2001-01-02 |
| BR9812875A (pt) | 2000-08-08 |
| US6015790A (en) | 2000-01-18 |
| DE69803792D1 (de) | 2002-03-21 |
| EP1021200A1 (en) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ310444A (en) | Novel dolastatin derivatives, their preparation and use | |
| AR017298A1 (es) | USO DE UN COMPUESTO DERIVADO DE DEPSIPEPTIDO DOLASTINA-15 (Dov-Val-NMeVal-Pro-Pro-Hiva-Dpy) PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA ELTRATAMIENTO DE ARTRITIS REUMATOIDEA EN UN MAMIFERO | |
| IL151371A0 (en) | Modified porcine factor viii and pharmaceutical compositions containing the same | |
| BR0204980B1 (pt) | Composições cosméticas que contêm pelo menos um silicone aminado e um agente espessante, uso de uma composição, uso de pelo menos um silicone aminado e processo de tratamento das matérias queratínicas | |
| BR0210322A (pt) | Composição limpadora perolada para cuidado pessoal | |
| MXPA02010945A (es) | Composiciones cosmeticas que contienen una silicona aminada y un agente espesante y sus utilizaciones. | |
| HUP0301842A2 (hu) | Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására | |
| BR0113524A (pt) | Composição antiperspirante e/ou desodorante sólida | |
| BR0015605A (pt) | Composição e uso | |
| BR0014486A (pt) | Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado | |
| CY1108090T1 (el) | Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων | |
| AR023529A1 (es) | Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello | |
| ATE309007T1 (de) | Transplantate für die wiederherstellung von osteochondralen schäden | |
| BRPI0619522B8 (pt) | conjugados de objetivação de vetor-fosfolipídio, composição compreendendo os referidos conjugados, composição de agente de contraste para ultra-som e método para preparo de microvesícula cheia de gás compreendendo um fosfolipídio e de fabricação de conjugado de peptídeo-fosfolipídio tendo baixos níveis de tfa | |
| ECSP055635A (es) | Agentes citotoxicos que contienen taxanos potentes novedosos y su uso terapeutico | |
| MD2353B2 (en) | Antibiotic preparation, process for obtaining and use thereof | |
| DE60219782D1 (de) | Pharmazeutische und/oder kosmetische zusammensetzung zur behandlung von lokaler adipositas und zellulitis | |
| MD2550B2 (en) | Antibiotic preparation with slows release of the active ingredient and use thereof | |
| BR0008341A (pt) | Sol orgânico, composto sólido, processo de preração de um sol, e, utilização de um sol | |
| DE50114342D1 (de) | Sphärische oxidische Partikel, Verfahren zu ihrer Herstellung und deren Verwendung | |
| BR0315663A (pt) | Formulações de depósito de agentes ativos de aril-heterocìclicos na forma de uma suspensão | |
| HUP0302099A2 (hu) | Az azithromicin monohidrátja, eljárás az előállítására és a monohidrátot tartalmazó gyógyszerkészítmény | |
| AU2002321232A1 (en) | Treatment of hair follicle with neurokinin 1 receptor antagonists | |
| BR9709556A (pt) | Dihidrobenzopirano e compostos a ele relacionados úteis como agentes antiflamatórios | |
| Xie et al. | Improved stability of plasma-sprayed dicalcium silicate/zirconia composite coating |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |